Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Choay

Showing results (41-50 of 99) with videos related to

Pageof 10
Sort By:
Thrombosis Research|December 15, 1988
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activityJ M Walenga, M Petitou, M Samama, et al.
Journal of Cellular Physiology|September 1, 1989
Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cellsT Bârzu, J C Lormeau, M Petitou, et al.
International Journal of Peptide and Protein Research|April 1, 1978
Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine)P Lefrancier, M Derrien, I Lederman, et al.
International Journal of Peptide and Protein Research|January 1, 1979
Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide endP Lefrancier, M Petitou, M Level, et al.
The Journal of Biological Chemistry|October 25, 1988
Biosynthesis of heparin. O-sulfation of the antithrombin-binding regionM Kusche, G Bäckström, J Riesenfeld, et al.
Biochemical and Biophysical Research Communications|September 7, 1976
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomersA Adam, M Devys, V Souvannavong, et al.
Annales Pharmaceutiques Francaises|July 1, 1976
[Purification and properties of plasminogens extracted from human placenta]J C Lormeau, J Choay, J Goulay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1977
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogsL Chedid, M Parant, F Parant, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivativesF Dol, M Petitou, J Choay, et al.
Journal of Molecular Biology|July 5, 1993
Crystal structure of cleaved bovine antithrombin III at 3.2 A resolutionL Mourey, J P Samama, M Delarue, et al.
Pageof 10

Showing results (41-50 of 99) with videos related to

Sort By:
Pageof 10
Thrombosis Research|December 15, 1988
Importance of a 3-O-sulfate group in a heparin pentasaccharide for antithrombotic activityJ M Walenga, M Petitou, M Samama, et al.
Journal of Cellular Physiology|September 1, 1989
Heparin-derived oligosaccharides: affinity for acidic fibroblast growth factor and effect on its growth-promoting activity for human endothelial cellsT Bârzu, J C Lormeau, M Petitou, et al.
International Journal of Peptide and Protein Research|April 1, 1978
Synthesis of some new analogs of the immunoadjuvant glycopeptide MDP (N-acetyl-muramyl-L-alanyl-D-isoglutamine)P Lefrancier, M Derrien, I Lederman, et al.
International Journal of Peptide and Protein Research|January 1, 1979
Synthesis of N-acetyl-muramyl-L-alanyl-D-glutamic-alpha-amide(MDP) or -alpha-methyl ester derivatives, bearing a lipophilic group at the C-terminal peptide endP Lefrancier, M Petitou, M Level, et al.
The Journal of Biological Chemistry|October 25, 1988
Biosynthesis of heparin. O-sulfation of the antithrombin-binding regionM Kusche, G Bäckström, J Riesenfeld, et al.
Biochemical and Biophysical Research Communications|September 7, 1976
Correlation of structure and adjuvant activity of N-acetyl muramyl-L-alanyl-D-isoglutamine (MDP), its derivatives and analogues. Anti-adjuvant and competition properties of stereoisomersA Adam, M Devys, V Souvannavong, et al.
Annales Pharmaceutiques Francaises|July 1, 1976
[Purification and properties of plasminogens extracted from human placenta]J C Lormeau, J Choay, J Goulay, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1977
Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogsL Chedid, M Parant, F Parant, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1989
Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivativesF Dol, M Petitou, J Choay, et al.
Journal of Molecular Biology|July 5, 1993
Crystal structure of cleaved bovine antithrombin III at 3.2 A resolutionL Mourey, J P Samama, M Delarue, et al.
Pageof 10